Home » Healthcare » Corneal Topographers Market

Corneal Topographers Market By Product Type (Placido Disc System, Scheimpflug Systems); By Application (Cataract Surgery Evaluation, Corneal Disorder Diagnosis); By End User (Hospitals, Ophthalmic Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Report ID: 35307 | Report Format : Excel, PDF

Corneal Topographers Market Overview:

Corneal Topographers Market size was valued USD 793 million in 2024 and is anticipated to reach USD 1172.21 million by 2032, at a CAGR of 5% during the forecast period.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Corneal Topographers Market Size 2024 USD 793 million
Corneal Topographers Market, CAGR 5%
Corneal Topographers Market Size 2032 USD 1172.21 million

Corneal Topographers Market Insights

  • Market growth is driven by rising refractive and cataract surgery volumes, increasing keratoconus screening, and strong demand for high-resolution corneal mapping and AI-enabled diagnostic accuracy in clinical practice.
  • Key trends include integration of topography with surgical planning software, adoption of multimodal topography–tomography systems, and growing preference for workflow-efficient platforms in high-volume ophthalmic clinics.
  • Competitive dynamics remain moderately consolidated, with leading players differentiating through software analytics, imaging precision, regulatory compliance, and long-term service support, while mid-tier players focus on cost-effective systems.
  • Regionally, North America leads with a 38% market share, while Asia-Pacific shows fastest growth; by segment, Placido disc systems remain dominant with an estimated share of about 45% due to clinical familiarity and cost efficiency.

Corneal Topographers Market Size

Corneal Topographers Market Segmentation Analysis:

By Product Type

The corneal topographers market by product type is led by Placido disc systems, which account for approximately 42% market share due to their widespread adoption in routine corneal curvature assessment and refractive screening. These systems are favored for their cost efficiency, fast data acquisition, and high repeatability in anterior corneal surface mapping. Scheimpflug systems follow, driven by their ability to generate three-dimensional corneal tomography and posterior surface data, supporting advanced diagnostics. Scanning slit systems maintain a niche presence, primarily used in academic and specialty settings requiring detailed corneal thickness profiling.

  • For instance, Presbia utilizes Placido-disc–based corneal mapping, a gold standard for assessing corneal surface regularity. These systems capture data at approximately 22,000 discrete reflection points per scan (consistent with your “over 20,000” figure).

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

 

By Application

By application, refractive surgery evaluation represents the dominant sub-segment with nearly 34% market share, supported by rising volumes of LASIK and other vision-correction procedures globally. Accurate pre-operative corneal mapping is critical to surgical planning and risk mitigation, driving sustained demand. Corneal disorder diagnosis holds a significant share due to increasing prevalence of keratoconus and corneal ectasia, while cataract surgery evaluation benefits from growing premium intraocular lens adoption. Contact lens fitting also contributes steadily, as topography-guided fitting improves comfort, visual outcomes, and long-term patient compliance.

  • For instance, AJL Ophthalmic’s corneal implants and diagnostic solutions are used alongside advanced topographic evaluation protocols that detect corneal thickness changes as small as 5–10 micrometers, supporting timely clinical intervention and post-implant follow-up in keratoconus management programs documented in company clinical use reports.

By End-User

Among end users, ophthalmic clinics dominate the market with an estimated 46% share, driven by high patient throughput, specialization in refractive and diagnostic eye care, and faster adoption of advanced diagnostic technologies. Clinics prioritize compact, user-friendly systems that integrate seamlessly into clinical workflows. Hospitals follow, supported by comprehensive ophthalmology departments and surgical volumes, while ambulatory surgery centers gain traction with the expansion of outpatient eye procedures. Other end users, including academic and research institutions, contribute modestly through training and clinical research activities.

Key Growth Drivers

Rising Prevalence of Refractive Errors and Corneal Disorders

The growing global burden of refractive errors, keratoconus, and other corneal irregularities is a primary driver for the corneal topographers market. Increasing screen exposure, aging populations, and lifestyle-related visual strain continue to elevate diagnostic demand. Corneal topographers play a critical role in early detection, disease staging, and longitudinal monitoring of corneal conditions, enabling clinicians to make precise, data-driven decisions. Their ability to generate detailed curvature, elevation, and thickness maps supports accurate diagnosis, strengthens clinical confidence, and drives consistent adoption across ophthalmic practices.

  • For instance, San Diego Eye Bank’s tissue-recovery network and processing systems supported a major research study in which human retinal samples it supplied were used for molecular analyses involving immunoblot assays with specific markers such as phosphorylated RIP1 (Ser166) and RIP3 (Thr231/Ser232), demonstrating the utility of its donated tissues in advanced neurodegenerative research models.

Expansion of Refractive and Cataract Surgery Volumes

Rising demand for refractive and premium cataract surgeries significantly accelerates the adoption of corneal topographers. Surgeons increasingly rely on advanced corneal mapping to optimize preoperative planning, assess corneal stability, and select appropriate intraocular lenses. Accurate topographic data reduces surgical risk, improves visual outcomes, and enhances patient satisfaction. As elective eye procedures grow in both developed and emerging markets, clinics and hospitals continue to invest in reliable topography systems as essential diagnostic infrastructure.

  • For instance, its Aurovue hydrophobic intraocular lens is engineered with a refractive index of 1.47 and enhanced optical design that minimizes chromatic aberration and facilitates controlled, flexible implantation during cataract surgery, advancing visual acuity performance in demanding surgical workflows.

Technological Advancements in Corneal Imaging Systems

Continuous innovation in imaging technologies strongly supports market growth. Modern corneal topographers integrate Placido-disc, Scheimpflug, and hybrid imaging modalities to deliver higher resolution, faster acquisition, and improved repeatability. Enhanced software analytics, automated reporting, and seamless integration with electronic medical records improve clinical workflow efficiency. These advancements lower operator dependency and expand usability across varied clinical settings, encouraging upgrades from legacy systems and supporting sustained replacement demand.

Key Trends & Opportunities

Integration of Multi-Modal and AI-Enabled Diagnostics

A key trend in the corneal topographers market is the integration of multi-modal imaging combined with artificial intelligence–driven analytics. AI-assisted pattern recognition enhances the detection of subtle corneal abnormalities and supports earlier diagnosis of progressive disorders. This trend improves diagnostic consistency across operators and creates opportunities for decision-support tools in refractive screening, postoperative monitoring, and disease progression analysis, particularly in high-volume ophthalmic centers.

  • For instance, keratoconus earlier by leveraging topographic indices across >4,000 mapped corneal data points per eye combined with optical coherence tomography (OCT) elevation data, demonstrating improved sensitivity to early ectatic changes documented in clinical machine-learning workflows.

Growing Adoption in Emerging Healthcare Markets

Emerging economies present strong growth opportunities due to expanding ophthalmic infrastructure and increasing access to eye care services. Rising awareness of vision correction options and investments in private eye clinics support demand for advanced diagnostic equipment. Corneal topographers are increasingly adopted as standard-of-care tools in these regions, driven by improving reimbursement environments, growing medical tourism, and the expansion of specialty ophthalmology networks.

  • For instance, The PRECISION7® 7-day contact lens utilizes the ACTIV-FLO® System, a sustained-release technology that replenishes moisture to provide 16 hours of comfort throughout a one-week replacement cycle.

Shift Toward Compact and Clinic-Friendly Systems

Manufacturers are increasingly focusing on compact, user-friendly corneal topographers designed for smaller clinics and ambulatory settings. Portable footprints, simplified interfaces, and faster examination times align with the needs of high-throughput practices. This trend supports wider penetration beyond large hospitals and creates opportunities for manufacturers to address underserved segments such as independent ophthalmic clinics and optometry centers.

Key Challenges

High Equipment Costs and Budget Constraints

The relatively high upfront cost of advanced corneal topography systems remains a key challenge, particularly for small clinics and facilities in cost-sensitive markets. Budget limitations can delay purchasing decisions or force reliance on older diagnostic technologies. Additionally, ongoing expenses related to software upgrades, maintenance, and calibration may further restrict adoption, especially where reimbursement for diagnostic procedures remains limited.

Need for Skilled Operation and Data Interpretation

Effective use of corneal topographers requires trained personnel capable of accurate image acquisition and clinical interpretation. Variability in operator expertise can affect data quality and diagnostic reliability. In regions facing shortages of skilled ophthalmic professionals, this challenge may limit optimal utilization of advanced systems. Addressing training gaps and simplifying interpretation through automation remains essential for broader market penetration.

Regional Analysis

North America

North America leads the corneal topographers market with an estimated 38% market share, supported by advanced ophthalmic infrastructure and high adoption of premium diagnostic technologies. Strong demand arises from large volumes of refractive and cataract surgeries, early uptake of AI-assisted corneal mapping, and widespread availability of skilled ophthalmologists. The United States dominates regional revenues due to routine pre- and post-operative corneal assessment standards, while Canada contributes steadily through modern eye-care facilities. Continuous investments by clinics in high-resolution and multimodal topography systems further reinforce North America’s leadership position.

Europe

Europe accounts for approximately 27% of the global corneal topographers market, driven by strong clinical adoption across Germany, France, the UK, Italy, and Spain. The region benefits from well-established public healthcare systems, rising screening for keratoconus, and growing refractive surgery volumes. European ophthalmic centers emphasize diagnostic accuracy and regulatory-compliant devices, supporting steady replacement demand for advanced topography platforms. Increased awareness of early corneal disorders and cross-border medical services also stimulate market growth, while Eastern Europe shows gradual expansion as access to specialized ophthalmic diagnostics improves.

Asia-Pacific

Asia-Pacific represents around 23% market share and is the fastest-growing regional market for corneal topographers. Growth is fueled by expanding ophthalmology infrastructure in China, India, Japan, and South Korea, alongside rising prevalence of myopia and corneal disorders. Rapid urbanization, increasing disposable income, and growing adoption of refractive surgeries drive demand for cost-effective yet technologically advanced systems. Government initiatives to improve eye-care access and the expansion of private ophthalmic chains further accelerate uptake, positioning Asia-Pacific as a key future growth engine.

Latin America

Latin America holds close to 7% of the global market, supported by improving access to specialized eye-care services in Brazil, Mexico, and Argentina. The region shows steady adoption of corneal topographers as private clinics expand refractive and cataract surgery offerings. Increasing awareness of corneal disease diagnosis and gradual modernization of ophthalmic equipment contribute to market growth. However, price sensitivity and uneven healthcare access across countries limit rapid penetration, resulting in moderate but consistent demand for mid-range and refurbished diagnostic systems.

Middle East & Africa

The Middle East & Africa region accounts for approximately 5% market share, with growth concentrated in the Gulf Cooperation Council countries and select African urban centers. Demand is driven by investments in advanced healthcare infrastructure, rising medical tourism, and increasing prevalence of diabetes-related ocular complications. Premium ophthalmology clinics in the Middle East adopt high-end corneal topography systems, while Africa shows emerging demand supported by international healthcare initiatives. Despite infrastructure gaps in some areas, gradual expansion of specialized eye-care services supports long-term market development.

Corneal Topographers Market Segmentations:

By Product Type:

  • Placido disc system
  • Scheimpflug systems

By Application:

  • Cataract surgery evaluation
  • Corneal disorder diagnosis

By End User:

  • Hospitals
  • Ophthalmic clinics

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Competitive Landscape

The competitive landscape of the corneal topographers market players such as , AJL Ophthalmic S.A., San Diego Eye Bank, Aurolab, KeraMed, Inc., Alcon Inc., DIOPTEX, Florida Lions Eye Bank, CorneaGen. The corneal topographers market features a moderately consolidated competitive landscape shaped by technological innovation, clinical accuracy, and strong service networks. Manufacturers primarily compete on high-resolution imaging, advanced corneal mapping algorithms, and software platforms that support refractive surgery planning and early diagnosis of corneal disorders. Continuous upgrades in AI-assisted analysis, multimodal imaging integration, and user-friendly interfaces enhance product differentiation. Companies also emphasize regulatory compliance, after-sales support, and clinician training to strengthen long-term relationships with hospitals and ophthalmic clinics. Strategic collaborations with research institutions and eye-care centers accelerate validation and adoption of new systems. Overall, competitive intensity remains steady, with innovation, reliability, and cost-effectiveness serving as the key determinants of market positioning and global expansion.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

 

Key Player Analysis

  • Presbia PLC
  • AJL Ophthalmic S.A.
  • San Diego Eye Bank
  • Aurolab
  • KeraMed, Inc.
  • Alcon Inc.
  • DIOPTEX
  • Florida Lions Eye Bank
  • CorneaGen
  • Massachusetts Eye and Ear

Recent Developments

  • In February 2025, OCULUS launched the Myopia Software Package for Pentacam AXL Wave, merging axial length and corneal tomography for integrated management. The new software is designed to offer optometrists unparalleled accuracy, ease, and safety in their myopia management, comprehensive screening.
  • In December 2024, EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space. EssilorLuxottica agreed to acquire Espansione Group, adding non-invasive ophthalmic treatment devices.
  • In September 2023, GitHub’s Innovation Graph is an open data platform providing interactive insights into public software development trends and the global impact of developers, particularly for researchers and policymakers.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Adoption of AI-driven corneal analysis will increase to support earlier and more accurate detection of corneal disorders.
  2. Integration of corneal topographers with refractive and cataract surgery planning systems will become standard practice.
  3. Demand will rise for multimodal devices combining topography, tomography, and pachymetry in a single platform.
  4. Portable and compact corneal topographers will gain traction in outpatient clinics and ambulatory settings.
  5. Software upgrades with cloud-based data storage and remote access will improve clinical workflow efficiency.
  6. Growing prevalence of myopia and keratoconus will sustain long-term diagnostic demand across age groups.
  7. Emerging markets will favor cost-effective systems with scalable functionality and local service support.
  8. Regulatory emphasis on diagnostic accuracy will encourage replacement of legacy imaging systems.
  9. Collaboration between manufacturers and ophthalmic research centers will accelerate technology validation.
  10. Increased patient awareness of preventive eye care will support routine corneal screening adoption.
  1. Introduction
    1.1. Report Description
    1.2. Purpose of the Report
    1.3. USP & Key Offerings
    1.4. Key Benefits for Stakeholders
    1.5. Target Audience
    1.6. Report Scope
    1.7. Regional Scope
  2. Scope and Methodology
    2.1. Objectives of the Study
    2.2. Stakeholders
    2.3. Data Sources
    2.3.1. Primary Sources
    2.3.2. Secondary Sources
    2.4. Market Estimation
    2.4.1. Bottom-Up Approach
    2.4.2. Top-Down Approach
    2.5. Forecasting Methodology
  3. Executive Summary
  4. Introduction
    4.1. Overview
    4.2. Key Industry Trends
  5. Global Corneal Topographers Market
    5.1. Market Overview
    5.2. Market Performance
    5.3. Impact of COVID-19
    5.4. Market Forecast
  6. Market Breakup by Product Type
    6.1. Placido Disc System
    6.1.1. Market Trends
    6.1.2. Market Forecast
    6.1.3. Revenue Share
    6.1.4. Revenue Growth Opportunity
    6.2. Scheimpflug Systems
    6.2.1. Market Trends
    6.2.2. Market Forecast
    6.2.3. Revenue Share
    6.2.4. Revenue Growth Opportunity
  7. Market Breakup by Application
    7.1. Cataract Surgery Evaluation
    7.1.1. Market Trends
    7.1.2. Market Forecast
    7.1.3. Revenue Share
    7.1.4. Revenue Growth Opportunity
    7.2. Corneal Disorder Diagnosis
    7.2.1. Market Trends
    7.2.2. Market Forecast
    7.2.3. Revenue Share
    7.2.4. Revenue Growth Opportunity
  8. Market Breakup by End User
    8.1. Hospitals
    8.1.1. Market Trends
    8.1.2. Market Forecast
    8.1.3. Revenue Share
    8.1.4. Revenue Growth Opportunity
    8.2. Ophthalmic Clinics
    8.2.1. Market Trends
    8.2.2. Market Forecast
    8.2.3. Revenue Share
    8.2.4. Revenue Growth Opportunity
  9. Market Breakup by Region
    9.1. North America
    9.1.1. United States
    9.1.1.1. Market Trends
    9.1.1.2. Market Forecast
    9.1.2. Canada
    9.1.2.1. Market Trends
    9.1.2.2. Market Forecast
    9.2. Asia-Pacific
    9.2.1. China
    9.2.2. Japan
    9.2.3. India
    9.2.4. South Korea
    9.2.5. Australia
    9.2.6. Indonesia
    9.2.7. Others
    9.3. Europe
    9.3.1. Germany
    9.3.2. France
    9.3.3. United Kingdom
    9.3.4. Italy
    9.3.5. Spain
    9.3.6. Russia
    9.3.7. Others
    9.4. Latin America
    9.4.1. Brazil
    9.4.2. Mexico
    9.4.3. Others
    9.5. Middle East and Africa
    9.5.1. Market Trends
    9.5.2. Market Breakup by Country
    9.5.3. Market Forecast
  10. SWOT Analysis
    10.1. Overview
    10.2. Strengths
    10.3. Weaknesses
    10.4. Opportunities
    10.5. Threats
  11. Value Chain Analysis
  12. Porter’s Five Forces Analysis
    12.1. Overview
    12.2. Bargaining Power of Buyers
    12.3. Bargaining Power of Suppliers
    12.4. Degree of Competition
    12.5. Threat of New Entrants
    12.6. Threat of Substitutes
  13. Price Analysis
  14. Competitive Landscape
    14.1. Market Structure
    14.2. Key Players
    14.3. Profiles of Key Players
    14.3.1. Presbia PLC
    14.3.1.1. Company Overview
    14.3.1.2. Product Portfolio
    14.3.1.3. Financials
    14.3.1.4. SWOT Analysis
    14.3.2. AJL Ophthalmic S.A.
    14.3.3. San Diego Eye Bank
    14.3.4. Aurolab
    14.3.5. KeraMed, Inc.
    14.3.6. Alcon Inc.
    14.3.7. DIOPTEX
    14.3.8. Florida Lions Eye Bank
    14.3.9. CorneaGen
    14.3.10. Massachusetts Eye and Ear
  15. Research Methodology
Request Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices


Providing the strategic compass for industry titans.

cr-clients-logos

Frequently Asked Questions:

What is the current market size for the Corneal Topographers Market, and what is its projected size in 2032?

The market was valued at USD 793 million in 2024 and is projected to reach USD 1172.21 million by 2032.

At what Compound Annual Growth Rate is the Corneal Topographers Market projected to grow between 2024 and 2032?

The market is expected to grow at a CAGR of 5% during the forecast period.

Which Corneal Topographers Market segment held the largest share in 2024?

Placido disc systems held the largest share due to widespread clinical adoption and cost efficiency.

What are the primary factors fueling the growth of the Corneal Topographers Market?

Rising refractive and cataract surgeries, increasing corneal disorder screening, and technological advancements in imaging systems drive growth.

Who are the leading companies in the Corneal Topographers Market?

The market includes a mix of ophthalmic device manufacturers, research institutions, and eye banks with strong clinical and technological expertise.

Which region commanded the largest share of the Corneal Topographers Market in 2024?

North America led the market with an exact 38% share, supported by advanced eye-care infrastructure and high procedure volumes.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Dilated Cardiomyopathy Therapeutics Market

The Dilated Cardiomyopathy Therapeutic Market size was estimated at USD 5,240.95 million in 2025 and is expected to reach USD 8,025.37 million by 2032, growing at a CAGR of 7.36% from 2025 to 2032.

Digital Pathology Image Analysis Market

The global Digital Pathology Image Analysis Market size was estimated at USD 3,425.85 million in 2025 and is expected to reach USD 7,503.83 million by 2032, growing at a CAGR of 13.96% from 2025 to 2032.

Divalproex Sodium Market

The Divalproex Sodium Market size was estimated at USD 1,860.58 million in 2025 and is expected to reach USD 2,453.73 million by 2032, growing at a CAGR of 4.72% from 2025 to 2032.

Somatostatin Analogs Market

The global somatostatin analogs market was valued at USD 7,187.5 million in 2024 and is projected to reach USD 12,349.46 million by 2032, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period.

Respiratory Disease Vaccine Market

The global respiratory disease vaccine market was valued at USD 94,579.5 million in 2024 and is projected to reach USD 102,011.14 million by 2032, expanding at a compound annual growth rate (CAGR) of 2.1% during the forecast period

Hepatic Encephalopathy Market

The hepatic encephalopathy market was valued at USD 1432.5 million in 2024 and is expected to reach USD 2176.7 million by 2032, registering a CAGR of 5.4% during the forecast period.

Cardiac Pacemakers Market

The cardiac pacemakers market was valued at USD 5,298 million in 2024 and is expected to reach USD 7,702.9 million by 2032. The market is projected to grow at a CAGR of 4.79% during the forecast period.

Cancer Immunotherapy Drug Discovery Outsourcing Market

The cancer immunotherapy drug discovery outsourcing market was valued at USD 1,432 million in 2024 and is expected to reach USD 2,981.48 million by 2032. The market is projected to grow at a CAGR of 9.6% during the forecast period.

Healthcare Cloud Infrastructure Market

The global healthcare cloud infrastructure market was valued at USD 76,788 million in 2024 and is projected to reach USD 260,555.1 million by 2032, expanding at a compound annual growth rate (CAGR) of 16.5% during the forecast period

Pregabalin Market

The pregabalin market reached USD 1,794.5 million in 2024 and is projected to reach USD 2,631.16 million by 2032, growing at a CAGR of 4.9% during the forecast period. (Credence Research Data)

Pregnancy Medication Market

The Pregnancy Medication market was valued at USD 42,234.5 million in 2024 and is expected to reach USD 124,770.3 million by 2032, expanding at a CAGR of 14.5% during the forecast period.

Germany Guidewires Market

The Germany guidewires market was valued at USD 151 million in 2024 and is projected to reach USD 229.68 million by 2032, registering a CAGR of 5.4% during the forecast period.

Licence Option

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Europe

North America

Email

Smallform of Sample request
User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

cr-clients-logos

Request Sample